Background. Neck management after radiotherapy remains controversial, It is
not clear which patients may benefit from postradiotherapy neck dissection
. Biologic markers may be useful in this setting.
Method. This study includes 81 patients with oral cavity and oropharyngeal
carcinomas. The primary tumor had been treated with radical radiotherapy. I
mmunohistochemical staining to p53, ki-67, NEU, HSP-27, and GST has been pe
rformed.
Results. There were 50 T1-2 and 31 T3-4 patients, as well as 36 N0 and 45 N
1-3. A total of 25 nodal failures was observed. With expressed HSP2, 23% of
patients had neck failure compared with 51% when HSP-27 was absent (p = .0
2). With NEU overexpression, nodal control decreased from 72% to 34% (p = .
008). In a Cox model, NEU (p = .01) and HSP-27 (p = .05) were associated wi
th neck failure.
Conclusions. HSP-27 and NEU expression may play a role in predicting nodal
failure. This should be confirmed in a larger, prospective study. (C) 2001
John Wiley & Sons, Inc.